Ontology highlight
ABSTRACT:
SUBMITTER: Zhang W
PROVIDER: S-EPMC2840060 | biostudies-literature | 2010 Mar
REPOSITORIES: biostudies-literature
Zhang Weiguo W Konopleva Marina M Burks Jared K JK Dywer Karen C KC Schober Wendy D WD Yang Jer-Yen JY McQueen Teresa J TJ Hung Mien-Chie MC Andreeff Michael M
Cancer research 20100309 6
Molecular aberrations of the Ras/Raf/mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/ERK and/or Murine double minute (MDM2)/p53 signaling pathways have been reported in 80% and 50% of primary acute myeloid leukemia (AML) samples and confer poor outcome. In this study, antileukemic effects of combined MEK inhibition by AZD6244 and nongenotoxic p53 activation by MDM2 antagonist Nutlin-3a were investigated. Simultaneous blockade of MEK and MDM2 signaling by ...[more]